Skip to content

Cefuroxime 125 mg/5 ml powder for suspension bottle 70.0 ml #1 ​

Manufacturer: Fidson healthcare , Nigeria

Composition: cefuroxime 25.0 mg/ml

Price: Not availableCefuroxime 125 mg/5 ml powder for suspension bottle 70.0 ml #1

What is the chemical name and molecular formula of Cefuroxime Axetil? ​

(RS)-1-hydroxyethyl (6R,7R)-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-(Z)-(O-methyl-oxime), 1-acetate 3-carbamate. C₂₀H₂₂N₄O₁₀S

What is the indicated dosage of Cefuroxime 125mg Suspension for uncomplicated urinary tract infections in adolescents and adults? ​

125mg twice a day for 7 days.

How should FIDSON Cefuroxime 125mg Suspension be prepared for administration? ​

Reconstituted with previously boiled and cooled water according to label instructions.

How does food intake affect the absorption of Cefuroxime Axetil? ​

Absorption is enhanced when taken after food.

What is the mechanism of action of Cefuroxime Axetil? ​

It is hydrolyzed to cefuroxime, which inhibits bacterial cell-wall synthesis.

What are some common adverse reactions associated with Cefuroxime Axetil? ​

Gastrointestinal disturbances (diarrhea, nausea, vomiting, abdominal pain).

Is Cefuroxime Axetil contraindicated for any specific patient population? ​

Patients with a known allergy to cephalosporin antibiotics.

What precautions should be taken when prescribing Cefuroxime Axetil? ​

Caution in patients with concurrent potent diuretics, history of colitis or gastrointestinal malabsorption. Prolonged use may lead to superinfection.

How is Cefuroxime excreted from the body? ​

Unchanged in the urine.

How should Cefuroxime 125mg/5ml powder for oral suspension be stored? ​

Below 30°C, protected from light and moisture, and out of reach of children.

What is the role of Probenecid when administered with Cefuroxime Axetil? ​

Increases the serum concentration-time curve by 50%.

What are some of the infections Cefuroxime Axetil Suspension is indicated for? ​

Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media, Acute Bacterial Maxillary Sinusitis, Acute Bacterial exacerbations of Chronic Bronchitis and Secondary Bacterial Infections of acute bronchitis, Uncomplicated Skin and Skin-Structure Infections, Uncomplicated Urinary Tract Infections, Uncomplicated Gonorrhea (urethral and endocervical), and Early Lyme Disease (erythema migrans).